Cortexyme (NASDAQ:CRTX – Get Rating) and Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Volatility & Risk Cortexyme has a beta of 1.4, […]